fundvisualizer.com

Hartford Balanced Income FHBLFX

Performance (before sales charge)

As of 02/29/2024

All information is historical and not indicative of future results. Current performance may be lower or higher than the quoted past performance, which cannot guarantee results. Share price, principal value, and return will vary, and you may have a gain or a loss when you sell your shares. Performance assumes reinvestment of distributions and does not account for taxes. After-sales-charge returns reflect the maximum sales charge applicable to the fund. Performance may not reflect any expense limitation or subsidies currently in effect. Short-term trading fees may apply. To obtain the most recent month-end performance, visit Morningstar.com.

Asset allocation

As of 02/29/2024
Stock
36.84%
Non-U.S. Stock
6.79%
Bond
39.28%
Non-U.S. Bond
14.60%
Preferred
0.20%
Convertible
0.11%
Cash
2.17%
Other
0.00%

Due to rounding, percentages may not equal 100%.

Sectors

As of 02/29/2024

Basic materials

2.59%

Consumer cyclical

1.61%

Financial services

8.83%

Real estate

2.75%

Consumer defensive

4.48%

Health care

7.28%

Utilities

3.71%

Communication services

0.26%

Energy

3.84%

Industrials

4.69%

Technology

3.58%

Top 10 holdings

As of 02/29/2024

Merck & Co Inc
1.75%
JPMorgan Chase & Co
1.53%
Usd
1.37%
Pfizer Inc
1.33%
Johnson & Johnson
1.27%
ConocoPhillips
1.27%
2 Year Treasury Note Future June 24
1.16%
Ultra 10 Year US Treasury Note Future June 24
1.04%
EOG Resources Inc
1.03%
Philip Morris International Inc
0.96%
Fund assets

$12.54 Billion

Share class

Other

Morningstar category

Moderately Conservative Allocation

Expense ratio

0.55%

Investment objective

Balanced

Documents